Aspiriant LLC’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-9,516
| Closed | -$602K | – | 212 |
|
|
2020
Q3 | $602K | Buy |
+9,516
| New | +$602K | 0.05% | 141 |
|
|
2020
Q2 | – | Sell |
-2,786
| Closed | -$209K | – | 186 |
|
|
2020
Q1 | $209K | Buy |
+2,786
| New | +$209K | 0.02% | 176 |
|
|
2019
Q3 | – | Sell |
-3,592
| Closed | -$241K | – | 220 |
|
|
2019
Q2 | $241K | Sell |
3,592
-59
| -2% | -$3.96K | 0.02% | 200 |
|
|
2019
Q1 | $236K | Sell |
3,651
-203
| -5% | -$13.1K | 0.02% | 204 |
|
|
2018
Q4 | $241K | Buy |
3,854
+326
| +9% | +$20.4K | 0.02% | 205 |
|
|
2018
Q3 | $272K | Sell |
3,528
-879
| -20% | -$67.8K | 0.02% | 205 |
|
|
2018
Q2 | $312K | Sell |
4,407
-2,590
| -37% | -$183K | 0.03% | 199 |
|
|
2018
Q1 | $527K | Buy |
+6,997
| New | +$527K | 0.05% | 150 |
|
|
2017
Q4 | – | Sell |
-4,418
| Closed | -$358K | – | 115 |
|
|
2017
Q3 | $358K | Buy |
4,418
+524
| +13% | +$42.5K | 0.03% | 153 |
|
|
2017
Q2 | $276K | Buy |
3,894
+950
| +32% | +$67.3K | 0.02% | 177 |
|
|
2017
Q1 | $201K | Buy |
+2,944
| New | +$201K | 0.02% | 202 |
|